Coronavirus Update - 09th November 2020

We would like to reassure our customers that as England enters its second national lockdown period, we remain open for business and at full capacity as we have done since the start of this pandemic and fully comply with all government guidance on minimising the risks of COVID-19.

As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

Drug Product

We leverage our extensive experience in the Chemistry, Manufacturing and Controls (CMC) aspects of molecule development for drug product manufacture. Our all-in-one facility allows us to develop, manufacture, test, release and supply a range of clinical product types. All of our individual offerings can be accessed either on a transactional basis, or as part of an integrated service.

View the QC & Molecule Development Equipment and Capabilities List

View the Manufacturing Equipment and Capabilities List